Published in Proteomics Weekly, March 12th, 2007
FUZEON, co-developed by Roche and Trimeris (Nasdaq: TRMS), is the first and only...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.